MARKET

XPH

XPH

Spdr® S&P Pharmaceuticals Etf
NYSEARCA

Real-time Quotes | Provided by Morningstar

40.85
+0.20
+0.49%
Closed 16:00 05/19 EDT
OPEN
40.35
PREV CLOSE
40.65
HIGH
41.06
LOW
40.35
VOLUME
29.34K
TURNOVER
592.36K
52 WEEK HIGH
53.82
52 WEEK LOW
37.94
TOTAL ASSET
185.93M
YTD YIELD
-4.44%
1D
5D
1M
3M
1Y
5Y
Tesla Loses Spot on S&P ESG Index on Crashes, Working Conditions
Bloomberg · 1d ago
Crypto ETP-Provider 21Shares Marks US Debut With Two Launches
Bloomberg · 1d ago
Software Stocks Pummeled Even Harder Than Rest of Tech Market
Bloomberg · 1d ago
Bond Traders Reel as Inflation Hits World’s Emerging Local Debt
Bloomberg · 3d ago
Grayscale Makes Europe Debut with Crypto ETF
Bloomberg · 4d ago
Cathie Wood Just Keeps Buying Coinbase and Getting More Inflows
Bloomberg · 5d ago
World's Richest Family Bet on Munis, Japanese Stocks, Coinbase
Bloomberg · 6d ago
Two Terra ETPs Suspend Operations After Crypto-Market Meltdown
Bloomberg · 6d ago
More
No Data
Learn about the latest financial forecast of XPH. Analyze the recent business situations of Spdr® S&P Pharmaceuticals Etf through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
08/31/2020
10 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
No Data
Profile
Fund Name
Spdr® S&P Pharmaceuticals Etf
Risk
Low risk
Inception Date
2006-06-19
Benchmark
Dow Jones US Healthcare TR
Advisor Company
State Street Global Advisors Ltd
Custodian
State Street Bank & Trust Co
Manager
Feehily/Schneider/Richardson